← Open Payments lookup

BRIAN MILLER: Open Payments

NPI 1861411381 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,194 in 62 payments from 14 companies in 2025. Trend: 2023 $21,888 · 2024 $24,595 · 2025 $21,194

Speaker / faculty: $9,180Consulting: $7,460Food & beverage: $2,250Travel & lodging: $2,154Honoraria: $150
CompanyPaymentsAmount
Alkermes, Inc.26$18,572
E.R. Squibb & Sons, L.L.C.13$1,739
Neurocrine BioSciences, Inc.7$334
H2-Pharma, LLC1$150
LivaNova USA, Inc.1$60
Otsuka America Pharmaceutical, Inc.2$52
Axsome Therapeutics, Inc.2$50
Vanda Pharmaceuticals Inc.2$49
Janssen Pharmaceuticals, Inc2$48
Otsuka Pharmaceutical Development & Commercialization, Inc.1$37

Products named: LYBALVI, COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, Auvelity, FANAPT.

Industry payments across CA — which companies pay providers there.